Two University of California San Diego researchers have received prestigious awards through the 2020 National Institutes of Health (NIH) High-Risk, High-Reward Research Program.
The University of California San Diego’s Holocaust Living History Workshop (HLHW) is returning this fall with a yearlong series of seven lectures that underscore the theme “Witnessing the Past: Holocaust Histories.”
Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.
UC San Diego Vice Chancellor for Research Sandra A. Brown has received two national recognitions for her pioneering research in the field of psychology from the APA and the NIAAA.
UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.
Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
